膜雌激素受体和卵泡刺激激素受体
Livio Casarini1, Manuela Simoni1
1Unit of Endocrinology, Dept. Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Vitamins and hormones
|September 17, 2023
概括
卵泡刺激激素 (FSH) 和雌激素膜受体在卵巢中相互作用. 这种相互作用影响生殖功能和卵泡命运,为人类生殖提供了新的见解.
科学领域:
- 生殖生物学 生殖生物学
- 内分泌学 在内分泌学.
- 分子信号传递是分子信号传递.
背景情况:
- 卵泡刺激激素 (FSH) 和雌激素对于繁殖至关重要.
- FSH膜受体 (FSHR) 和G蛋白结合雌激素受体 (GPER) 是关键的参与者.
- 通过GPER调解雌激醇的快速,非基因组效应,促进细胞增殖和存活.
研究的目的:
- 研究FSHR和GPER在卵巢中的共同表征和相互作用.
- 了解这些受体如何调节细胞内信号通路.
- 探索它们在决定卵泡命运中的作用 (缩与主导).
主要方法:
- 在卵巢组织中FSHR和GPER的共同表征.
- 通过这些受体调节的细胞内信号级联的分析.
- 研究潜在的物理相互作用和异构组合的形成.
主要成果:
- FSHR和GPER在卵巢中表现出明显的和重叠的信号调制.
- 受体表达水平和卵泡发育阶段影响信号结果.
- 有证据表明FSHR和GPER之间存在物理相互作用,形成异构体复合体.
结论:
- FSH和雌激素膜受体的相互作用代表了生殖调节中的新机制.
- 了解这些受体动力学可以更深入地了解人类生殖.
- 这种知识对于理解卵泡命运和生殖健康至关重要.
相关概念视频
Hormonal Regulation of the Menstrual Cycle
430
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
430
Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
Internal Receptors
70.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
70.3K
Intracellular Hormone Receptors
55.5K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
55.5K
Types of Receptors: Internal Receptors
25.5K
Many cellular signals are hydrophilic and cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind intracellular receptors that reside within the cell cytoplasm or nucleus. Many mammalian steroid hormones and nitric oxide (NO) gas use this cell signaling mechanism.
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
25.5K
Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K


